Open original FDA record ↗Recall record
- FDA identifier
- Z-1513-2018
- Company in FDA record
- BioFire Diagnostics, LLC
- FDA classification date
- Apr 25, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is an increased risk of false positive Proteus results when the product is used with specific types of BD BACTEC blood culture bottles.
Source facts
- Action
- The recalling firm initiated the recall on several different dates and methods: Via email on 3/14/2018 with the letter dated 3/3/2018 attached, via USPS on 3/23/2018, and via FedEx between 3/24/2018 and 3/28/2018. The recalling firm conducted an expansion and issued letters dated 6/11/2018 via FedEx or USPS on 6/13/2018.
- Initiated
- 2018-03-14
- Root cause
- Material/Component Contamination
- Terminated
- 2018-10-24
- Distribution
- Distribution was nationwide. There was military/government distribution. Foreign distribution was made to Canada, Algeria, Argentina, Australia, Austria, Bahrain, Botswana, Brazil, Chile, Colombia, Costa Rica, Czech Republic, Dominican Republic, Ecuador, Egypt, France, French Polynesia, Georgia, Germany, Greece, Guatemala, Hong Kong, India, Iraq, Israel, Italy, Japan, Jordan, Republic of Korea, Kuwait, Lebanon, Malaysia, Mexico, Myanmar, The Netherlands, New Caledonia, Nicaragua, Panama, Peru, Republic of the Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, Uganda, United Arab Emirates, United Kingdom, Uruguay.
- Recall number
- Z-1513-2018
- Recall status
- Terminated
- CDRH record ID
- 162542
- FDA classified
- 2018-04-25
- Recall event number
- 79514